FDA Warns Danish Device Manufacturer for MDR, CGMP Violations
The Food and Drug Administration sent a warning letter dated Nov. 19 to MedArt A/S, a Danish medical device manufacturer, detailing violations of medical device reporting regulations and current good manufacturing practices. FDA ordered the firm to respond within 15…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
business days of receipt. The warning letter did not specify any consequences for failure to comply.